To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene HMGB2TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
402 supporting clones for gene HMGB2 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
AI523803 B-cell, chronic lymphotic leukemia .a 1 to 794 1 to 789   tiling clone, Submitted on the opposite strand 789/792
(99 %)
26 diff
(96.8 %id)
AI862617 B-cell, chronic lymphotic leukemia .a 1 to 621 1 to 621     Submitted on the opposite strand 621/621
(100 %)
17 diff
(97.3 %id)
NM_001130689.1   .a 58 to 1511 1 to 1454   RefSeq,   1454/1454
(100 %)
0 diff
(100 %id)
BM781845 myeloma .a 58 to 634 1 to 577   tiling clone,   577/577
(100 %)
0 diff
(100 %id)
AA688186 germinal center B cell .a 85 to 463 1 to 375     Submitted on the opposite strand 375/375
(100 %)
7 diff
(98.2 %id)
BG613939 embryonal carcinoma, testis .b 1 to 628 1 to 634   tiling clone,   634/952
(66 %)
9 diff
(99.1 %id)
BG177580 lymph, lymphoma, cell line .b 19 to 768 1 to 745       745/913
(81 %)
12 diff
(98.7 %id)
BE409577 choriocarcinoma, placenta .b 24 to 824 1 to 802 A160C A161C Y162I R163S A164C ...     802/802
(100 %)
9 diff
(98.9 %id)
BU540073 mixed (pool of 40 RNAs) .b 32 to 1041 1 to 1018 P6S W49R E188K E194G E204R ...     1018/1034
(98 %)
54 diff
(94.8 %id)
AU077317   .b 33 to 216 1 to 184       184/185
(99 %)
1 diff
(99.5 %id)
AU100294   .b 33 to 332 1 to 300       300/300
(100 %)
1 diff
(99.7 %id)
DA613668   .b 34 to 606 2 to 575   capped   574/574
(100 %)
2 diff
(99.7 %id)
AU310693 neuroblastoma .b 34 to 626 8 to 600       593/600
(98 %)
6 diff
(99.0 %id)
BP381008   .b 34 to 581 1 to 548       548/550
(99 %)
7 diff
(98.8 %id)
AK311864 brain .b 35 to 797 1 to 763 exact     763/763
(100 %)
0 diff
(100 %id)
BP206762 coronary artery .b 35 to 619 1 to 585       585/585
(100 %)
3 diff
(99.5 %id)
NM_001130688.1   .b 35 to 1501 1 to 1467 exact RefSeq,   1467/1467
(100 %)
0 diff
(100 %id)
BM743197 stomach .b 35 to 620 1 to 586       586/586
(100 %)
0 diff
(100 %id)
DA511698 brain .b 36 to 597 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DA616397   .b 36 to 621 2 to 587   capped   586/586
(100 %)
0 diff
(100 %id)
DA752761   .b 36 to 606 2 to 571   capped   570/570
(100 %)
2 diff
(99.7 %id)
BQ277209 mixed (pool of 40 RNAs) .b 37 to 877 1 to 847 K147X K152X E156X D158G I159Y ...     847/914
(92 %)
28 diff
(97.0 %id)
BG614124 embryonal carcinoma, testis .b 39 to 874 1 to 838 N77T Y78L V79R P80S P81S ...     838/903
(92 %)
32 diff
(96.5 %id)
BG615704 embryonal carcinoma, testis .b 39 to 753 1 to 720       720/725
(99 %)
13 diff
(98.3 %id)
AU129620   .b 41 to 722 2 to 686   fully sequenced, capped   685/685
(100 %)
6 diff
(99.2 %id)
CN309227 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 46 to 555 1 to 510       510/510
(100 %)
0 diff
(100 %id)
DR155976 human embryonic stem cells differentiated toan early endodermal cell type .b 46 to 838 1 to 793 E188K     793/793
(100 %)
1 diff
(99.9 %id)
BE390283 endometrium, adenocarcinoma cell line, uterus .b 47 to 588 1 to 546       546/548
(99 %)
8 diff
(98.6 %id)
BE389138 endometrium, adenocarcinoma cell line, uterus .b 47 to 717 1 to 666       666/669
(99 %)
10 diff
(98.6 %id)
BE386536 melanotic melanoma, skin .b 47 to 699 1 to 648       648/684
(94 %)
7 diff
(99.0 %id)
CN309216 embryonic stem cells, DMSO-treated H9 cellline .b 48 to 661 1 to 615       613/615
(99 %)
5 diff
(99.2 %id)
AW246077 lung, small cell carcinoma .b 53 to 578 1 to 526       526/526
(100 %)
4 diff
(99.3 %id)
AW250100 lung, small cell carcinoma .b 53 to 654 1 to 602       602/602
(100 %)
10 diff
(98.4 %id)
BG337425 leiomyosarcoma cell line, uterus .b 56 to 831 1 to 775 P178Q T179Q G180A S181Q K182R ...     775/775
(100 %)
5 diff
(99.4 %id)
BM006052 hepatocellular carcinoma, cell line, Liver .b 57 to 763 1 to 712       712/744
(95 %)
14 diff
(98.2 %id)
TI_59386005   .b 58 to 763 109 to 819       711/743
(95 %)
13 diff
(98.3 %id)
BQ647668 hepatocellular carcinoma, cell line, Liver .b 59 to 892 1 to 840 E188K D189X E190X E195G E196K ...     840/920
(91 %)
21 diff
(97.8 %id)
AA355867   .b 62 to 359 1 to 298       298/298
(100 %)
1 diff
(99.7 %id)
BI870551 adenocarcinoma, cell line, Liver .b 63 to 854 10 to 812 E193D E194D E196R E197R D198R ...     803/948
(84 %)
30 diff
(96.9 %id)
TI_57229475   .b 63 to 854 10 to 812 E193D E194D E196R E197R D198R ...     803/1017
(78 %)
30 diff
(97.1 %id)
CN309264 embryonic stem cells, DMSO-treated H9 cellline .b 70 to 335 1 to 266       266/266
(100 %)
1 diff
(99.7 %id)
BU176350 eye, retinoblastoma .b 71 to 566 1 to 504       504/836
(60 %)
15 diff
(98.3 %id)
BC100019 Skin, melanotic melanoma. .b 73 to 1175 1 to 1102 exact tiling clone, AAA   1102/1102
(100 %)
1 diff
(100.0 %id)
BU189417 melanotic melanoma, skin .b 74 to 866 1 to 799 E188X D189N E190X E192G E196X ...     799/825
(96 %)
15 diff
(98.2 %id)
CN309215 embryonic stem cells, DMSO-treated H9 cellline .b 88 to 723 1 to 636       636/636
(100 %)
3 diff
(99.6 %id)
CN309279 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 88 to 688 1 to 602       602/602
(100 %)
1 diff
(99.9 %id)
BQ652454 hepatocellular carcinoma, cell line, Liver .b 128 to 1067 23 to 972 E188K E196K     950/989
(96 %)
38 diff
(96.2 %id)
AU310694 neuroblastoma .b 627 to 1176 551 to 6       546/551
(99 %)
0 diff
(100 %id)
AU151712   .b 692 to 1175 483 to 1   tiling clone, fully sequenced,   483/483
(100 %)
0 diff
(100 %id)
CR600021 T cells (Jurkat cell line) .c 1 to 1876 1 to 1876 exact tiling clone,   1876/1876
(100 %)
0 diff
(100 %id)
BX443642 T cells (Jurkat cell line) .c 1 to 693 1 to 692       692/692
(100 %)
3 diff
(99.6 %id)
TI_151769727   .c 67 to 658 102 to 695       594/1407
(42 %)
6 diff
(99.6 %id)
BG035546 adenocarcinoma, cell line, Liver .c 86 to 158 1 to 73       73/73
(100 %)
0 diff
(100 %id)
BX409867 T cells (Jurkat cell line) .c 579 to 1469 1 to 887       887/887
(100 %)
16 diff
(98.2 %id)
NM_002129.3   .c 682 to 2208 1 to 1527 exact RefSeq,   1527/1527
(100 %)
0 diff
(100 %id)
AU129699   .c 686 to 1465 2 to 790   capped   789/804
(98 %)
19 diff
(97.7 %id)
TI_154178914   .c 688 to 1435 76 to 824       749/919
(81 %)
12 diff
(98.7 %id)
TI_154178981   .c 688 to 1433 69 to 811       743/980
(75 %)
8 diff
(99.2 %id)
FN139154 breast carcinoma .c 694 to 780 1 to 87       87/87
(100 %)
4 diff
(95.5 %id)
AW958534   .c 702 to 1369 1 to 668       668/668
(100 %)
4 diff
(99.5 %id)
BQ069599 brain, neuroblastoma, cell line .c 713 to 1440 1 to 729       729/1055
(69 %)
11 diff
(99.0 %id)
BJ996693 hepatoblastoma .c 720 to 1252 1 to 533       533/533
(100 %)
0 diff
(100 %id)
BQ923392 brain, neuroblastoma, cell line .c 726 to 1578 1 to 853 E188K E190X E192G E196X E203G     853/853
(100 %)
7 diff
(99.2 %id)
BM800494 leiomyosarcoma, uterus .c 727 to 1672 1 to 954 E188X D189Y E192G E196K E197K ...     954/1111
(85 %)
67 diff
(94.0 %id)
BG392978 embryonal carcinoma, cell line, testis .c 728 to 1380 1 to 653       653/653
(100 %)
0 diff
(100 %id)
CR622092 fetal liver .c 729 to 1870 1 to 1142 exact     1142/1142
(100 %)
0 diff
(100 %id)
CR624893 neuroblastoma .c 729 to 1883 1 to 1155 exact     1155/1155
(100 %)
0 diff
(100 %id)
BM723895 eye, fetal eye .c 733 to 1369 1 to 637   fully sequenced,   637/637
(100 %)
0 diff
(100 %id)
BM149288 leukopheresis .c 735 to 1291 1 to 557       557/557
(100 %)
4 diff
(99.3 %id)
TI_59391850   .c 746 to 1435 54 to 743       688/695
(98 %)
3 diff
(99.6 %id)
AA092427   .c 751 to 904 1 to 153       153/153
(100 %)
8 diff
(94.8 %id)
AW582711 stomach .c 755 to 1336 602 to 23       580/615
(94 %)
9 diff
(98.6 %id)
BF796438 lymph, lymphoma, cell line .c 755 to 1600 1 to 842 G174A P175L G176A R177G P178Q ...     842/884
(95 %)
29 diff
(96.8 %id)
BQ231908 embryonal carcinoma, cell line, testis .c 755 to 1535 1 to 781 P178A S181F D189Y E192G E196K ...     781/877
(89 %)
16 diff
(98.2 %id)
BU187077 eye, retinoblastoma .c 755 to 1643 1 to 891 E188X D189N E190X E201X     891/892
(99 %)
17 diff
(98.1 %id)
X62534   .c 755 to 1947 95 to 1288 exact AAA   1194/1229
(97 %)
7 diff
(99.5 %id)
CV804305 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .c 756 to 1569 1 to 819 A164G K182Q E196K E201*     819/881
(92 %)
30 diff
(96.6 %id)
BM693600 eye, fetal eyes .c 756 to 1369 1 to 614   fully sequenced,   614/614
(100 %)
0 diff
(100 %id)
CN309212 embryonic stem cells, DMSO-treated H9 cellline .c 759 to 1179 1 to 421       421/421
(100 %)
5 diff
(98.9 %id)
FN095200 breast carcinoma .c 760 to 845 1 to 85       85/85
(100 %)
5 diff
(94.2 %id)
BU172831 eye, retinoblastoma .c 762 to 1706 1 to 945 D189N E190X E192X E196X E197X     945/945
(100 %)
10 diff
(99.0 %id)
CN309232 embryonic stem cells, DMSO-treated H9 cellline .c 764 to 1395 1 to 632       632/632
(100 %)
0 diff
(100 %id)
BQ931572 epidermoid carcinoma, cell line, lung .c 765 to 1542 1 to 782 E188Q E190X E196K     782/855
(91 %)
7 diff
(99.2 %id)
BM723742 eye, fetal eye .c 765 to 1433 1 to 669       669/669
(100 %)
0 diff
(100 %id)
AU108061   .c 766 to 815 1 to 50       50/50
(100 %)
0 diff
(100 %id)
AU108060   .c 768 to 817 1 to 50       50/50
(100 %)
0 diff
(100 %id)
BP247265 Kidney .c 768 to 1349 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BE252235 eye, retinoblastoma .c 768 to 1401 1 to 632       632/642
(98 %)
7 diff
(99.0 %id)
BP328970 rectum .c 768 to 1348 1 to 581       581/581
(100 %)
0 diff
(100 %id)
BM741154 Ascites, stomach .c 768 to 1366 1 to 599       599/599
(100 %)
0 diff
(100 %id)
AU133250   .c 769 to 1555 2 to 795 exact fully sequenced, capped   794/794
(100 %)
2 diff
(99.8 %id)
BM848569 myeloma .c 769 to 1090 1 to 322       322/322
(100 %)
0 diff
(100 %id)
DB103428 thymus .c 769 to 1342 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
DB131241 thymus .c 769 to 1319 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
DB132461 thymus .c 769 to 1300 2 to 533   capped   532/532
(100 %)
0 diff
(100 %id)
DB140344 thymus .c 769 to 1329 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
DB144465 thymus .c 769 to 1307 2 to 540   capped   539/539
(100 %)
0 diff
(100 %id)
DB149053 thymus .c 769 to 1235 2 to 468   capped   467/467
(100 %)
0 diff
(100 %id)
DB189028 liver, tumor tissue .c 769 to 1351 2 to 584   capped   583/583
(100 %)
0 diff
(100 %id)
BM763839 myeloma .c 770 to 1320 1 to 551       551/551
(100 %)
0 diff
(100 %id)
CX165170 human embryonic stem cells differentiated toan early endodermal cell type .c 772 to 1619 1 to 848 E188X     848/848
(100 %)
5 diff
(99.5 %id)
BP284296 bone marrow .c 773 to 1365 1 to 593       593/593
(100 %)
0 diff
(100 %id)
BM742354 Ascites, stomach .c 773 to 1391 1 to 619       619/619
(100 %)
0 diff
(100 %id)
BM755836 Ascites, stomach .c 773 to 1105 1 to 333       333/333
(100 %)
0 diff
(100 %id)
BM770625 Ascites, stomach .c 773 to 1432 1 to 660       660/660
(100 %)
0 diff
(100 %id)
BM771492 Ascites, stomach .c 773 to 1244 1 to 472       472/472
(100 %)
0 diff
(100 %id)
BM761936 myeloma .c 773 to 1365 1 to 593       593/593
(100 %)
0 diff
(100 %id)
BP364045 lung .c 773 to 1355 1 to 583       583/583
(100 %)
0 diff
(100 %id)
FN048984 breast carcinoma .c 774 to 878 104 to 1     Submitted on the opposite strand 104/104
(100 %)
1 diff
(99.1 %id)
DB469166 hippocampus .c 774 to 1212 1 to 440       440/440
(100 %)
35 diff
(92.1 %id)
CR590265 thymus .c 777 to 1860 1 to 1084 exact     1084/1084
(100 %)
0 diff
(100 %id)
BX436501 thymus .c 777 to 1861 1 to 1080 A170X fully sequenced,   1080/1080
(100 %)
20 diff
(98.2 %id)
DB138820 thymus .c 778 to 1318 2 to 542   capped   541/541
(100 %)
0 diff
(100 %id)
CN309236 embryonic stem cells, DMSO-treated H9 cellline .c 779 to 1534 1 to 756 E188*     756/756
(100 %)
4 diff
(99.5 %id)
DR155952 human embryonic stem cells differentiated toan early endodermal cell type .c 779 to 1551 1 to 773 E188K     773/773
(100 %)
1 diff
(99.9 %id)
BM800082 leiomyosarcoma, uterus .c 780 to 1765 1 to 996 E188X E197K     996/1012
(98 %)
16 diff
(98.5 %id)
CN309213 embryonic stem cells, cell lines H1, H7, andH9 .c 781 to 1432 1 to 652       652/652
(100 %)
0 diff
(100 %id)
CR592990 Placenta Cot 25-normalized .c 781 to 1868 1 to 1088 exact     1088/1088
(100 %)
0 diff
(100 %id)
BQ929625 leiomyosarcoma, uterus .c 782 to 1653 1 to 879 E188X     879/879
(100 %)
9 diff
(99.0 %id)
BU508888 leiomyosarcoma, uterus .c 782 to 1611 1 to 833 exact     833/868
(95 %)
13 diff
(98.6 %id)
CN309273 embryonic stem cells, DMSO-treated H9 cellline .c 786 to 1394 1 to 609       609/609
(100 %)
0 diff
(100 %id)
CR624665 thymus .c 787 to 1850 1 to 1064 exact     1064/1064
(100 %)
0 diff
(100 %id)
BX456501 thymus .c 787 to 1201 1 to 414   fully sequenced,   414/414
(100 %)
2 diff
(99.6 %id)
BU664711 blood .c 788 to 1424 1 to 637       637/637
(100 %)
0 diff
(100 %id)
EL955168 eyeball .c 789 to 1357 47 to 614       568/614
(92 %)
14 diff
(97.8 %id)
DR156039 human embryonic stem cells differentiated toan early endodermal cell type .c 789 to 1383 1 to 595       595/595
(100 %)
0 diff
(100 %id)
BC000903 Placenta, choriocarcinoma .c 790 to 1882 1 to 1093 E196* available from MGC, AAA   1093/1093
(100 %)
2 diff
(99.9 %id)
CX757168 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .c 790 to 1556 1 to 757 E186D E188X E197K D198R E199*   Submitted on the opposite strand 757/860
(88 %)
19 diff
(97.8 %id)
TI_57173151   .c 791 to 1498 36 to 744       709/751
(94 %)
15 diff
(98.1 %id)
BC021054 Placenta, choriocarcinoma .c 793 to 1883 10 to 1100 exact AAA   1091/1725
(63 %)
1 diff
(100.0 %id)
BM563389 astrocytoma grade IV, cell line, brain .c 793 to 1669 1 to 881 E188K E197Q     881/1059
(83 %)
17 diff
(98.4 %id)
CN309282 embryonic stem cells, DMSO-treated H9 cellline .c 795 to 1547 1 to 755 E188I D189R E190*     755/755
(100 %)
3 diff
(99.7 %id)
TI_57190620   .c 795 to 1501 87 to 795       707/710
(99 %)
5 diff
(99.3 %id)
TI_59380727   .c 795 to 1274 58 to 548       491/801
(61 %)
20 diff
(97.6 %id)
AA093291   .c 796 to 1016 1 to 207       207/225
(92 %)
17 diff
(92.5 %id)
BE900374 choriocarcinoma, placenta .c 798 to 1508 1 to 711 exact     711/711
(100 %)
0 diff
(100 %id)
CN309229 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 800 to 1321 1 to 522       522/522
(100 %)
0 diff
(100 %id)
CN309272 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 800 to 1549 1 to 750 E197K     750/750
(100 %)
1 diff
(99.9 %id)
CR622334 Placenta Cot 25-normalized .c 802 to 1883 1 to 1082 exact     1082/1082
(100 %)
0 diff
(100 %id)
AL545657 placenta, Placenta Cot 25-normalized .c 802 to 1883 1 to 1081 exact fully sequenced,   1081/1081
(100 %)
5 diff
(99.6 %id)
CN309252 embryonic stem cells, DMSO-treated H9 cellline .c 804 to 1407 1 to 604       604/604
(100 %)
0 diff
(100 %id)
BG257211 embryonal carcinoma, cell line, testis .c 804 to 1502 1 to 700       700/700
(100 %)
8 diff
(98.9 %id)
BM454424 lymph, lymphoma, cell line .c 804 to 1759 1 to 960 exact     960/1054
(91 %)
10 diff
(99.1 %id)
BQ433194 embryonal carcinoma, cell line, testis .c 804 to 1669 1 to 866 E188X D189N     866/871
(99 %)
2 diff
(99.8 %id)
BQ439044 embryonal carcinoma, cell line, testis .c 804 to 1669 1 to 868 exact     868/875
(99 %)
6 diff
(99.4 %id)
CV815964 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .c 805 to 1524 1 to 720 exact     720/720
(100 %)
2 diff
(99.8 %id)
TI_154194199   .c 805 to 1577 51 to 819 K167X A170S E190D E209K     769/1033
(74 %)
13 diff
(98.8 %id)
CN309221 embryonic stem cells, DMSO-treated H9 cellline .c 806 to 1179 1 to 374       374/374
(100 %)
0 diff
(100 %id)
BQ051645 blood, natural killer cells, cell line .c 806 to 1768 1 to 961 E188X D189N E196K     961/964
(99 %)
18 diff
(98.2 %id)
TI_154140959   .c 808 to 1364 80 to 636       557/557
(100 %)
1 diff
(99.9 %id)
BE279526 choriocarcinoma, placenta .c 812 to 1456 1 to 641       641/724
(88 %)
13 diff
(98.3 %id)
BM463231 embryonal carcinoma, cell line, testis .c 815 to 1814 1 to 1006 E188X E196X D205G E206*     1006/1006
(100 %)
31 diff
(97.0 %id)
CN309217 embryonic stem cells, DMSO-treated H9 cellline .c 817 to 1366 1 to 550       550/550
(100 %)
0 diff
(100 %id)
CN309228 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 817 to 1159 1 to 343       343/343
(100 %)
0 diff
(100 %id)
CN309251 embryonic stem cells, DMSO-treated H9 cellline .c 818 to 1366 1 to 549       549/549
(100 %)
0 diff
(100 %id)
CX783898 human embryonic stem cells .c 819 to 1603 1 to 785 exact     785/785
(100 %)
0 diff
(100 %id)
BC001063 Placenta, choriocarcinoma .c 822 to 1882 1 to 1061 exact available from MGC, AAA   1061/1061
(100 %)
0 diff
(100 %id)
CN309277 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 838 to 1229 8 to 399       392/399
(98 %)
0 diff
(100 %id)
AI802428   .c 838 to 1576 1 to 738 G123X K167X E190X E193X E194X ...   Submitted on the opposite strand 738/738
(100 %)
56 diff
(92.5 %id)
CN309270 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 844 to 1432 1 to 589       589/589
(100 %)
0 diff
(100 %id)
AA355862   .c 845 to 1139 1 to 295       295/295
(100 %)
0 diff
(100 %id)
CR623074 thymus .c 852 to 1871 1 to 1020 exact     1020/1020
(100 %)
0 diff
(100 %id)
BX437794 thymus .c 852 to 1113 1 to 262   fully sequenced,   262/262
(100 %)
0 diff
(100 %id)
AI133236 Liver .c 861 to 1530 672 to 1 K8N M13X V20R Q21A T22D ...     672/682
(98 %)
10 diff
(98.6 %id)
CN309268 embryonic stem cells, DMSO-treated H9 cellline .c 869 to 1431 1 to 563       563/563
(100 %)
0 diff
(100 %id)
AA521127 germinal center B cell .c 869 to 1287 1 to 419     Submitted on the opposite strand 419/419
(100 %)
0 diff
(100 %id)
TI_1948090100   .c 869 to 1274 120 to 525       406/428
(94 %)
6 diff
(98.6 %id)
TI_1948090361   .c 869 to 1362 122 to 615       494/516
(95 %)
9 diff
(98.3 %id)
TI_1948099944   .c 869 to 1404 126 to 661       536/559
(95 %)
5 diff
(99.2 %id)
TI_1948100116   .c 869 to 1347 125 to 603   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 479/501
(95 %)
6 diff
(98.9 %id)
AI017915 pooled .c 872 to 1283 26 to 436     Submitted on the opposite strand 411/461
(89 %)
34 diff
(92.7 %id)
TI_1948099600   .c 874 to 1459 124 to 710       587/674
(87 %)
13 diff
(98.1 %id)
BT019782   .c 875 to 1503 1 to 629       629/630
(99 %)
1 diff
(99.9 %id)
BT019783   .c 875 to 1503 1 to 626       626/627
(99 %)
2 diff
(99.7 %id)
CV023173 mixed .c 875 to 1440 1 to 566       566/566
(100 %)
0 diff
(100 %id)
TI_1948099770   .c 878 to 1460 132 to 712       581/622
(93 %)
15 diff
(97.6 %id)
BF804045 colon_ins .c 882 to 1060 191 to 12     Submitted on the opposite strand 180/194
(92 %)
7 diff
(96.4 %id)
TI_1948089980   .c 882 to 1510 745 to 119       627/1434
(43 %)
24 diff
(98.4 %id)
FN148019 breast carcinoma .c 902 to 995 95 to 1     Submitted on the opposite strand 95/112
(84 %)
1 diff
(99.2 %id)
CD614114   .c 904 to 1388 541 to 59       483/541
(89 %)
0 diff
(100 %id)
EL948914 eyeball .c 921 to 1517 1 to 597       597/597
(100 %)
2 diff
(99.7 %id)
BF912862 uterus_tumor .c 926 to 1482 573 to 17     Submitted on the opposite strand 557/573
(97 %)
1 diff
(99.9 %id)
DW407556 Liver .c 928 to 1438 547 to 39   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 509/547
(93 %)
5 diff
(99.1 %id)
AI393610 pooled .c 928 to 1252 8 to 332     Submitted on the opposite strand 330/332
(99 %)
5 diff
(98.5 %id)
Z17240   .c 944 to 1883 1 to 940       940/1066
(88 %)
3 diff
(99.8 %id)
BI025775 marrow .c 966 to 1343 386 to 13       374/386
(96 %)
1 diff
(99.8 %id)
FN126844 breast carcinoma .c 973 to 1052 1 to 79       79/80
(98 %)
4 diff
(95.0 %id)
CR606584 B cells (Ramos cell line) .c 979 to 1883 1 to 905       905/905
(100 %)
0 diff
(100 %id)
BX421328 B cells (Ramos cell line) .c 979 to 1879 1 to 901   fully sequenced,   901/901
(100 %)
1 diff
(99.9 %id)
ES313698 beard hair, skin .c 980 to 1584 1 to 605       605/605
(100 %)
9 diff
(98.6 %id)
BG942760 blood .c 992 to 1341 1 to 350       350/350
(100 %)
0 diff
(100 %id)
BM796502 Ascites, stomach .c 1006 to 1421 1 to 416       416/416
(100 %)
0 diff
(100 %id)
BU195588 eye, retinoblastoma .c 1017 to 1882 1 to 868   AAA   868/868
(100 %)
5 diff
(99.5 %id)
TI_154123574   .c 1023 to 2023 1090 to 92   tiling clone, AAA   999/1068
(93 %)
57 diff
(94.7 %id)
GD137864   .c 1027 to 1492 1 to 466   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 466/472
(98 %)
8 diff
(98.4 %id)
GD138056   .c 1027 to 1492 1 to 466   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 466/472
(98 %)
8 diff
(98.4 %id)
GD152686   .c 1027 to 1091 1 to 65       65/80
(81 %)
2 diff
(97.5 %id)
CN309240 embryonic stem cells, cell lines H1, H7, andH9 .c 1028 to 1272 1 to 245       245/245
(100 %)
0 diff
(100 %id)
FN073547 breast carcinoma .c 1031 to 1098 1 to 69       69/70
(98 %)
6 diff
(91.5 %id)
CR605441 Neuroblastoma Cot 25-normalized .c 1038 to 1883 1 to 846       846/846
(100 %)
0 diff
(100 %id)
AL527804 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .c 1038 to 1883 1 to 846   fully sequenced,   846/846
(100 %)
0 diff
(100 %id)
TI_149310648   .c 1053 to 1882 913 to 91   AAA   823/929
(88 %)
14 diff
(98.5 %id)
BG110484 Bone, osteosarcoma, cell line .c 1057 to 1775 1 to 718       718/720
(99 %)
2 diff
(99.8 %id)
TI_149278259   .c 1057 to 1882 910 to 91   AAA   820/1055
(77 %)
14 diff
(98.7 %id)
TI_149292341   .c 1057 to 1882 893 to 79   AAA   815/915
(89 %)
15 diff
(98.4 %id)
TI_154125193   .c 1057 to 1882 897 to 86   AAA   817/937
(87 %)
29 diff
(97.0 %id)
TI_227712602   .c 1057 to 1882 898 to 87   AAA   814/946
(86 %)
16 diff
(98.4 %id)
BF887006 testis_normal .c 1070 to 1329 260 to 4     Submitted on the opposite strand 257/262
(98 %)
2 diff
(99.3 %id)
AW389220 stomach .c 1074 to 1228 155 to 1       155/155
(100 %)
1 diff
(99.4 %id)
TI_151775068   .c 1077 to 1872 83 to 891       809/1115
(72 %)
28 diff
(97.5 %id)
BX437793 thymus .c 1083 to 1871 787 to 1   fully sequenced,   787/787
(100 %)
2 diff
(99.8 %id)
TI_149298683   .c 1085 to 1882 873 to 87   AAA   787/922
(85 %)
11 diff
(98.9 %id)
BQ018560 lung, Metastatic Chondrosarcoma .c 1096 to 1882 797 to 19   AAA   781/814
(95 %)
14 diff
(98.3 %id)
TI_149292491   .c 1096 to 1882 839 to 62   AAA   778/884
(88 %)
13 diff
(98.6 %id)
TI_227715509   .c 1096 to 1882 863 to 86   AAA   778/946
(82 %)
18 diff
(98.1 %id)
TI_151756496   .c 1096 to 1882 867 to 88   AAA   780/892
(87 %)
12 diff
(98.7 %id)
CR599927 fetal liver .c 1129 to 1883 1 to 755       755/755
(100 %)
0 diff
(100 %id)
BX405788 fetal liver, Liver .c 1129 to 1883 1 to 755   fully sequenced,   755/755
(100 %)
4 diff
(99.5 %id)
AW605184 denis_drash .c 1130 to 1686 563 to 5       559/563
(99 %)
4 diff
(99.3 %id)
AW608831 pnet .c 1133 to 1697 569 to 1       569/571
(99 %)
49 diff
(91.5 %id)
BG177394 lymph, lymphoma, cell line .c 1138 to 1844 1 to 711       711/759
(93 %)
13 diff
(98.3 %id)
BX456500 thymus .c 1140 to 1850 713 to 1   fully sequenced,   713/713
(100 %)
3 diff
(99.6 %id)
BX436500 thymus .c 1140 to 1850 714 to 1   fully sequenced,   714/714
(100 %)
4 diff
(99.5 %id)
AL545627 placenta, Placenta Cot 25-normalized .c 1140 to 1814 675 to 1   fully sequenced,   675/675
(100 %)
4 diff
(99.5 %id)
BM695106 eye, human retina .c 1142 to 1376 1 to 235   fully sequenced,   235/235
(100 %)
0 diff
(100 %id)
BM696111 eye, human retina .c 1142 to 1376 1 to 235   fully sequenced,   235/235
(100 %)
0 diff
(100 %id)
BF742554 breast .c 1159 to 1403 284 to 42     Submitted on the opposite strand 243/284
(85 %)
12 diff
(95.8 %id)
TI_154144829   .c 1168 to 1693 85 to 616       532/567
(93 %)
44 diff
(92.3 %id)
BE003062 breast_normal .c 1171 to 1531 385 to 22     Submitted on the opposite strand 364/392
(92 %)
5 diff
(98.8 %id)
BF380916 uterus_tumor .c 1171 to 1442 289 to 18       272/324
(83 %)
10 diff
(97.0 %id)
ES315873 melanoma cell line .c 1171 to 1617 545 to 97     Submitted on the opposite strand 449/548
(81 %)
3 diff
(99.5 %id)
TI_159697123   .c 1171 to 1882 787 to 78   AAA   710/1007
(70 %)
27 diff
(97.4 %id)
AW951026   .c 1176 to 1849 679 to 1     Submitted on the opposite strand 679/699
(97 %)
13 diff
(98.2 %id)
BG222128 moderate to poorly differentiated invasivecarcinoma, tongue .c 1176 to 1447 307 to 36       272/314
(86 %)
0 diff
(100 %id)
TI_149291516   .c 1179 to 1882 788 to 88   AAA   701/886
(79 %)
33 diff
(96.3 %id)
CA422660 cell lines, Chondrosarcoma .c 1179 to 1882 721 to 19   AAA   703/703
(100 %)
1 diff
(99.9 %id)
BM975395 lung, Primary Lung Cystic Fibrosis EpithelialCells .c 1181 to 1882 719 to 19   AAA   701/701
(100 %)
1 diff
(99.9 %id)
TI_151707202   .c 1184 to 1884 789 to 91       699/1217
(57 %)
9 diff
(99.3 %id)
AW837857 leiomios .c 1186 to 1530 364 to 21       344/364
(94 %)
1 diff
(99.8 %id)
BI063605 uterus_tumor .c 1187 to 1477 279 to 1       256/280
(91 %)
29 diff
(89.7 %id)
TI_154105135   .c 1188 to 1882 781 to 87   AAA   695/697
(99 %)
0 diff
(100 %id)
BM974535 lung .c 1192 to 1882 709 to 19   AAA   691/691
(100 %)
0 diff
(100 %id)
BE172284 head_neck .c 1193 to 1525 333 to 1     Submitted on the opposite strand 333/356
(93 %)
4 diff
(98.9 %id)
BQ007111 Chondrosarcoma, Left Pelvis .c 1196 to 1882 705 to 19   AAA   687/687
(100 %)
0 diff
(100 %id)
BQ574550 Chondrosarcoma Grade II, Left Pelvis .c 1196 to 1882 705 to 19   AAA   687/687
(100 %)
0 diff
(100 %id)
BU618357 Cell Line, Chondrosarcoma .c 1196 to 1882 705 to 19   AAA   687/687
(100 %)
0 diff
(100 %id)
BU622346 Cell Line, Chondrosarcoma .c 1196 to 1882 703 to 19   AAA   685/685
(100 %)
2 diff
(99.8 %id)
BU633047 cell lines, Chondrosarcoma .c 1196 to 1882 705 to 19   AAA   687/687
(100 %)
0 diff
(100 %id)
BU688926 lung .c 1198 to 1882 703 to 19   AAA   685/685
(100 %)
0 diff
(100 %id)
BU621098 cell lines, Chondrosarcoma .c 1198 to 1882 703 to 19   AAA   685/685
(100 %)
0 diff
(100 %id)
CD366958 Alveolar Macrophage, lung .c 1198 to 1882 703 to 19   AAA   685/685
(100 %)
0 diff
(100 %id)
CA748925 cell lines, Chondrosarcoma .c 1199 to 1885 703 to 19   AAA   685/685
(100 %)
2 diff
(99.8 %id)
BM458768 lymph, lymphoma, cell line .c 1200 to 1882 1 to 683   AAA   683/683
(100 %)
0 diff
(100 %id)
CB250512 Human Lung Epithelial cells, lung .c 1202 to 1882 699 to 19   AAA   681/692
(98 %)
3 diff
(99.6 %id)
CA446416 Chondrosarcoma, Left Pubic Bone .c 1207 to 1882 694 to 19   AAA   676/676
(100 %)
0 diff
(100 %id)
EL945939 eyeball .c 1208 to 1437 2 to 232       231/232
(99 %)
6 diff
(97.5 %id)
BY998953   .c 1210 to 1783 1 to 576     Submitted on the opposite strand 576/576
(100 %)
3 diff
(99.5 %id)
BY999805   .c 1210 to 1781 1 to 573     Submitted on the opposite strand 573/574
(99 %)
3 diff
(99.5 %id)
BG954812 colon .c 1231 to 1515 292 to 4       289/292
(98 %)
0 diff
(100 %id)
BU618961 Cell Line, Chondrosarcoma .c 1232 to 1882 669 to 19   AAA   651/651
(100 %)
0 diff
(100 %id)
CA416107 Chondrosarcoma Cell line .c 1233 to 1882 668 to 19   AAA   650/650
(100 %)
0 diff
(100 %id)
CD678232 eye, Trabecular meshwork .c 1234 to 1829 1 to 596       596/596
(100 %)
0 diff
(100 %id)
CA425522 Bone, Subchondral Bone .c 1234 to 1882 667 to 19   AAA   649/649
(100 %)
0 diff
(100 %id)
CA425614 cell lines, Chondrosarcoma .c 1234 to 1882 666 to 19   AAA   648/648
(100 %)
1 diff
(99.9 %id)
CA425618 cell lines, Chondrosarcoma .c 1234 to 1882 666 to 19   AAA   648/648
(100 %)
1 diff
(99.9 %id)
BU618225 Cell Line, Chondrosarcoma .c 1234 to 1882 667 to 19   AAA   649/649
(100 %)
0 diff
(100 %id)
BF170233 blood .c 1241 to 1442 1 to 202       202/202
(100 %)
25 diff
(87.7 %id)
BF896914 marrow .c 1241 to 1408 192 to 27     Submitted on the opposite strand 166/193
(86 %)
0 diff
(100 %id)
BX435859 B cells (Ramos cell line) .c 1243 to 1880 639 to 1   fully sequenced,   639/639
(100 %)
3 diff
(99.6 %id)
BX405787 fetal liver, Liver .c 1243 to 1873 631 to 1   fully sequenced,   631/631
(100 %)
0 diff
(100 %id)
BM989383 Fibrosarcoma .c 1245 to 1882 655 to 19   AAA   637/637
(100 %)
1 diff
(99.9 %id)
CA424876 cell lines, Chondrosarcoma .c 1246 to 1885 658 to 19   AAA   640/640
(100 %)
0 diff
(100 %id)
BU678346 lung .c 1253 to 1882 648 to 19   AAA   630/630
(100 %)
0 diff
(100 %id)
CA941700 Pancreas, Purified pancreatic islet .c 1256 to 1883 640 to 13     Submitted on the opposite strand 628/640
(98 %)
0 diff
(100 %id)
TI_153987888   .c 1260 to 1309 719 to 670       50/50
(100 %)
1 diff
(98.0 %id)
BF095616 uterus_tumor .c 1265 to 1723 459 to 1       459/459
(100 %)
7 diff
(98.5 %id)
CU447220 epidermis .c 1284 to 1632 9 to 357       349/373
(93 %)
8 diff
(97.9 %id)
BM670321 eye, lens .c 1287 to 1882 614 to 19   AAA   596/596
(100 %)
0 diff
(100 %id)
TI_154000783   .c 1297 to 1882 680 to 91   AAA   590/947
(62 %)
11 diff
(98.9 %id)
BF000249 colon, colon tumor, RER+ .c 1310 to 1421 112 to 1       112/112
(100 %)
5 diff
(95.6 %id)
BE080948 breast .c 1311 to 1676 391 to 26     Submitted on the opposite strand 366/391
(93 %)
0 diff
(100 %id)
AL527803 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .c 1315 to 1869 555 to 1   fully sequenced,   555/555
(100 %)
0 diff
(100 %id)
BM666880 eye, human retina .c 1315 to 1882 586 to 19   fully sequenced, AAA   568/568
(100 %)
1 diff
(99.9 %id)
BM664395 eye, human retina .c 1315 to 1882 586 to 19   fully sequenced, AAA   568/568
(100 %)
1 diff
(99.9 %id)
BM669186 eye, fetal eyes .c 1315 to 1882 585 to 19   fully sequenced, AAA   567/567
(100 %)
1 diff
(99.9 %id)
BM680060 eye, fetal eye .c 1315 to 1882 586 to 19   fully sequenced, AAA   568/568
(100 %)
1 diff
(99.9 %id)
CB159545 Liver .c 1327 to 1882 555 to 1     Submitted on the opposite strand 555/555
(100 %)
1 diff
(99.9 %id)
AW795283 uterus .c 1331 to 1524 194 to 1       194/194
(100 %)
0 diff
(100 %id)
AW795295 uterus .c 1331 to 1528 220 to 23       198/220
(90 %)
0 diff
(100 %id)
AW866948 stomach_normal .c 1331 to 1745 416 to 3       414/416
(99 %)
0 diff
(100 %id)
BQ360662 ovary .c 1331 to 1528 223 to 26       198/223
(88 %)
0 diff
(100 %id)
BM459864 leiomyosarcoma, uterus .c 1335 to 1882 1 to 548       548/552
(99 %)
1 diff
(99.9 %id)
AW167852 cervix .c 1337 to 1882 546 to 1       546/546
(100 %)
0 diff
(100 %id)
CA414473 Chondrosarcoma Grade II, Left Pelvis .c 1340 to 1882 561 to 19   AAA   543/543
(100 %)
0 diff
(100 %id)
BM785481 myeloma .c 1342 to 1862 1 to 521       521/521
(100 %)
0 diff
(100 %id)
BX414280 T cells (Jurkat cell line) .c 1347 to 1876 529 to 1       529/645
(82 %)
17 diff
(97.4 %id)
CB161172 Liver .c 1347 to 1882 536 to 1     Submitted on the opposite strand 536/536
(100 %)
0 diff
(100 %id)
FN111376 breast carcinoma .c 1354 to 1435 1 to 85       85/86
(98 %)
4 diff
(95.4 %id)
CB161160 Liver .c 1354 to 1882 529 to 1     Submitted on the opposite strand 529/529
(100 %)
0 diff
(100 %id)
BM668707 eye, Retina Foveal and Macular .c 1355 to 1882 542 to 15   AAA   528/528
(100 %)
0 diff
(100 %id)
BM784609 myeloma .c 1357 to 1751 1 to 395       395/395
(100 %)
0 diff
(100 %id)
DN918878   .c 1366 to 1881 517 to 3       515/517
(99 %)
0 diff
(100 %id)
AI905275 breast .c 1368 to 1830 494 to 33       462/494
(93 %)
0 diff
(100 %id)
FN162449 breast carcinoma .c 1370 to 1440 81 to 13     Submitted on the opposite strand 69/81
(85 %)
0 diff
(100 %id)
FN088186 breast carcinoma .c 1373 to 1457 1 to 82       82/83
(98 %)
4 diff
(95.2 %id)
BG059618 brain, glioblastoma without EGFR amplification .c 1376 to 1882 507 to 1       507/507
(100 %)
0 diff
(100 %id)
TI_57228460   .c 1376 to 1866 146 to 639       494/758
(65 %)
6 diff
(99.3 %id)
BF999227 placenta_normal .c 1379 to 1528 161 to 12       150/163
(92 %)
0 diff
(100 %id)
AW802295 uterus .c 1387 to 1776 398 to 9       390/398
(97 %)
0 diff
(100 %id)
BE047170 squamous cell carcinoma, tongue .c 1389 to 1883 495 to 1       495/495
(100 %)
0 diff
(100 %id)
BQ314801 denis_drash .c 1391 to 1653 331 to 66       266/331
(80 %)
0 diff
(100 %id)
BE882796 leiomyosarcoma, uterus .c 1392 to 1877 1 to 486       486/486
(100 %)
0 diff
(100 %id)
BM727941 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .c 1392 to 1949 1 to 558   tiling clone, AAA   558/558
(100 %)
0 diff
(100 %id)
BQ335110 marrow .c 1405 to 1659 260 to 2       259/267
(97 %)
0 diff
(100 %id)
AI338618 lung .c 1410 to 1881 472 to 1       472/472
(100 %)
0 diff
(100 %id)
BE645929 Prostate .c 1410 to 1883 474 to 1       474/474
(100 %)
0 diff
(100 %id)
BU632239 cell lines, Chondrosarcoma .c 1413 to 1882 488 to 19   AAA   470/470
(100 %)
0 diff
(100 %id)
CN309258 embryonic stem cells, DMSO-treated H9 cellline .c 1429 to 1882 1 to 454   AAA   454/454
(100 %)
0 diff
(100 %id)
AW799215 uterus .c 1433 to 1592 159 to 1       159/159
(100 %)
5 diff
(96.9 %id)
AI745038 ovary, tumor, 5 pooled (see description) .c 1434 to 1882 449 to 1       449/449
(100 %)
0 diff
(100 %id)
AI954175 normal epithelium, ovary .c 1434 to 1887 454 to 1       454/454
(100 %)
0 diff
(100 %id)
AI954999 four pooled poorly-differentiatedadenocarcinomas, lung .c 1434 to 1882 465 to 17   AAA   449/449
(100 %)
0 diff
(100 %id)
BG402989 bladder, transitional cell papilloma, cell line .c 1447 to 1882 1 to 436   AAA   436/436
(100 %)
0 diff
(100 %id)
AW152603 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .c 1450 to 1883 434 to 1       434/434
(100 %)
0 diff
(100 %id)
BJ996694 hepatoblastoma .c 1454 to 1882 451 to 23   AAA   429/429
(100 %)
0 diff
(100 %id)
AI434252 lymph node, lymphoma, follicular mixed small and largecell .c 1457 to 1882 452 to 27   AAA   426/426
(100 %)
0 diff
(100 %id)
AA702683 liver and spleen .c 1466 to 1882 417 to 1       417/417
(100 %)
0 diff
(100 %id)
AA629547 lung, lung carcinoma .c 1466 to 1882 417 to 1       417/417
(100 %)
0 diff
(100 %id)
AI033448 liver and spleen .c 1468 to 1882 415 to 1       415/415
(100 %)
0 diff
(100 %id)
BI036694 nervous_tumor .c 1474 to 1845 376 to 4       373/376
(99 %)
0 diff
(100 %id)
CD614112   .c 1479 to 1835 360 to 4       357/364
(98 %)
0 diff
(100 %id)
BU537432 mixed (pool of 40 RNAs) .c 1486 to 1877 1 to 392   AAA   392/392
(100 %)
0 diff
(100 %id)
BM150060 leukopheresis .c 1488 to 1883 411 to 16       396/411
(96 %)
0 diff
(100 %id)
AA969082 pooled .c 1489 to 1882 404 to 11   AAA   394/394
(100 %)
0 diff
(100 %id)
AI560067 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .c 1489 to 1883 395 to 1       395/395
(100 %)
0 diff
(100 %id)
AA977914 Kidney, kidney tumor .c 1499 to 1882 384 to 1       384/384
(100 %)
0 diff
(100 %id)
AA586616 germ cell tumor .c 1501 to 1877 377 to 1       377/377
(100 %)
0 diff
(100 %id)
BI026338 marrow .c 1504 to 1705 350 to 149       202/350
(57 %)
0 diff
(100 %id)
FN119935 breast carcinoma .c 1504 to 1582 77 to 1     Submitted on the opposite strand 77/88
(87 %)
2 diff
(97.8 %id)
AA553817 colon, tumor .c 1508 to 1881 374 to 1       374/374
(100 %)
0 diff
(100 %id)
BM974131 lung .c 1521 to 1882 380 to 19   AAA   362/362
(100 %)
0 diff
(100 %id)
AU154621   .c 1525 to 1882 355 to 1   fully sequenced,   355/355
(100 %)
1 diff
(99.8 %id)
BF448466 skin, normal, 4 pooled samples .c 1531 to 1888 358 to 1       358/358
(100 %)
0 diff
(100 %id)
BP429085   .c 1536 to 1879 348 to 5       344/348
(98 %)
0 diff
(100 %id)
TI_151809380   .c 1543 to 1882 78 to 417   AAA   340/340
(100 %)
0 diff
(100 %id)
BM930116 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .c 1544 to 1882 1 to 339   fully sequenced, AAA   339/339
(100 %)
0 diff
(100 %id)
AA301344 testis .c 1546 to 1858 313 to 1     Submitted on the opposite strand 313/313
(100 %)
0 diff
(100 %id)
TI_149309416   .c 1547 to 1882 433 to 97   AAA   337/589
(57 %)
6 diff
(99.0 %id)
FN063962 breast carcinoma .c 1552 to 1645 1 to 93       93/93
(100 %)
5 diff
(94.7 %id)
FN059130 breast carcinoma .c 1556 to 1645 1 to 91       91/91
(100 %)
1 diff
(99.0 %id)
BQ027233 mixed .c 1567 to 1882 334 to 19   AAA   316/316
(100 %)
0 diff
(100 %id)
AW063793 thymus .c 1573 to 1648 76 to 1     Submitted on the opposite strand 76/76
(100 %)
2 diff
(97.4 %id)
AA281827 germinal center B cell .c 1596 to 1824 229 to 1     Submitted on the opposite strand 229/229
(100 %)
1 diff
(99.6 %id)
AA188857   .c 1601 to 1848 257 to 1     Submitted on the opposite strand 257/257
(100 %)
10 diff
(96.2 %id)
CN309214 embryonic stem cells, DMSO-treated H9 cellline .c 1602 to 1883 285 to 4     Submitted on the opposite strand 282/285
(98 %)
0 diff
(100 %id)
FN146040 breast carcinoma .c 1608 to 1706 97 to 1     Submitted on the opposite strand 97/101
(96 %)
2 diff
(98.1 %id)
BQ423431 embryonal carcinoma, cell line, testis .c 1611 to 1882 1 to 272   AAA   272/272
(100 %)
0 diff
(100 %id)
BG661048   .c 1616 to 1882 1 to 267   AAA   267/267
(100 %)
0 diff
(100 %id)
CN309266 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 1617 to 1882 1 to 266   AAA   266/266
(100 %)
0 diff
(100 %id)
CN309284 embryonic stem cells, DMSO-treated H9 cellline .c 1618 to 1764 1 to 147       147/147
(100 %)
0 diff
(100 %id)
CA436707 Bone, Subchondral Bone .c 1639 to 1882 262 to 19   AAA   244/244
(100 %)
0 diff
(100 %id)
CN309278 embryonic stem cells, cell lines H1, H7, andH9 .c 1646 to 1882 247 to 11   AAA Submitted on the opposite strand 237/237
(100 %)
1 diff
(99.6 %id)
T29013 blood, white blood cells .c 1654 to 1883 235 to 4     Submitted on the opposite strand 232/235
(98 %)
0 diff
(100 %id)
CN309254 embryonic stem cells, DMSO-treated H9 cellline .c 1660 to 1882 235 to 11   AAA Submitted on the opposite strand 225/225
(100 %)
10 diff
(95.6 %id)
BU752637 placenta .c 1663 to 1882 237 to 18   AAA   220/220
(100 %)
0 diff
(100 %id)
FN150881 breast carcinoma .c 1667 to 1747 1 to 79       79/80
(98 %)
4 diff
(95.0 %id)
FN132053 breast carcinoma .c 1684 to 1791 107 to 1     Submitted on the opposite strand 107/108
(99 %)
3 diff
(97.3 %id)
BM684747 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .c 1698 to 1882 203 to 19   fully sequenced, AAA   185/185
(100 %)
0 diff
(100 %id)
CN309263 embryonic stem cells, cell lines H1, H7, andH9 .c 1715 to 1882 1 to 168   AAA   168/168
(100 %)
0 diff
(100 %id)
AA381132   .c 1721 to 1882 162 to 1       162/162
(100 %)
0 diff
(100 %id)
CN309245 embryonic stem cells, DMSO-treated H9 cellline .c 1750 to 1882 1 to 133   AAA   133/133
(100 %)
0 diff
(100 %id)
BG113057 Bone, osteosarcoma, cell line .c 1753 to 1883 135 to 4     Submitted on the opposite strand 132/136
(97 %)
0 diff
(100 %id)
BG113145 Bone, osteosarcoma, cell line .c 1753 to 1883 134 to 4     Submitted on the opposite strand 131/135
(97 %)
0 diff
(100 %id)
AA167412   .c 1760 to 1883 1 to 124   fully sequenced,   124/124
(100 %)
0 diff
(100 %id)
BE883400 leiomyosarcoma, uterus .c 1771 to 1882 133 to 22   AAA Submitted on the opposite strand 112/112
(100 %)
0 diff
(100 %id)
AA167413   .c 1823 to 1883 61 to 1   fully sequenced,   61/61
(100 %)
0 diff
(100 %id)
AA585145   .c 1946 to 2018 73 to 1   tiling clone,   73/73
(100 %)
0 diff
(100 %id)
BG529476 embryonal carcinoma, testis .d 1 to 633 7 to 645 W145G V146* tiling clone,   643/648
(99 %)
13 diff
(98.0 %id)
BM916513 amelanotic melanoma, cell line, skin .d 32 to 1056 1 to 1027   tiling clone, AAA   1027/1027
(100 %)
22 diff
(97.9 %id)
BM762295 myeloma .d 248 to 554 16 to 322       306/322
(95 %)
6 diff
(98.2 %id)
BG533753 Liver .e 1 to 561 2 to 566 K106P D107G I108Y A109C A110C ... tiling clone,   566/882
(64 %)
10 diff
(98.9 %id)
BQ052015 blood, natural killer cells, cell line .f 1 to 1039 1 to 1041 exact tiling clone,   1041/1049
(99 %)
9 diff
(99.2 %id)
BM762154 myeloma .f 47 to 733 1 to 687 exact     687/687
(100 %)
0 diff
(100 %id)
CN309241 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .f 508 to 784 1 to 277   tiling clone,   277/277
(100 %)
4 diff
(98.6 %id)
CA941419 Pancreas, Purified pancreatic islet .g 1 to 390 1 to 390   tiling clone, Submitted on the opposite strand 390/390
(100 %)
3 diff
(99.3 %id)
BI045039 ovary .g 116 to 645 30 to 559       530/570
(92 %)
7 diff
(98.8 %id)
BI045070 ovary .g 116 to 645 30 to 559       530/570
(92 %)
7 diff
(98.8 %id)
AI065067 Liver .g 138 to 791 1 to 652   tiling clone,   652/652
(100 %)
2 diff
(99.7 %id)
W60823 heart .g 551 to 1065 1 to 515   tiling clone, fully sequenced,   515/515
(100 %)
7 diff
(98.7 %id)
W60824 heart .g 1055 to 1505 453 to 1   tiling clone, fully sequenced,   453/453
(100 %)
2 diff
(99.6 %id)
CR603881 fetal brain .h 1 to 1841 1 to 1841 exact tiling clone,   1841/1841
(100 %)
0 diff
(100 %id)
BX418732 brain, fetal brain .h 1 to 1086 1 to 1077 exact fully sequenced,   1077/1077
(100 %)
5 diff
(99.6 %id)
DB106117 thymus .h 9 to 545 2 to 539 exact capped   538/562
(95 %)
2 diff
(99.7 %id)
BG530562 embryonal carcinoma, testis .h 34 to 395 1 to 362   AAA   362/362
(100 %)
1 diff
(99.8 %id)
CD705975 normal nasopharynx .h 41 to 398 23 to 380       358/380
(94 %)
7 diff
(98.2 %id)
DW451959 Liver .h 42 to 398 17 to 373       357/373
(95 %)
10 diff
(97.4 %id)
BM823059 stomach .h 45 to 364 1 to 320       320/320
(100 %)
0 diff
(100 %id)
CN309234 embryonic stem cells, cell lines H1, H7, andH9 .h 82 to 700 1 to 618 K55T E56R K57S S58R K59S ...     618/618
(100 %)
8 diff
(98.8 %id)
CN309211 embryonic stem cells, cell lines H1, H7, andH9 .h 152 to 614 30 to 492 exact     468/492
(95 %)
6 diff
(98.8 %id)
DW439472 Liver .h 449 to 674 17 to 242       226/242
(93 %)
6 diff
(97.6 %id)
AA310129   .h 650 to 1339 1 to 695       695/712
(97 %)
20 diff
(97.2 %id)
BF919700 nervous_tumor .h 858 to 1132 18 to 295       278/295
(94 %)
6 diff
(98.0 %id)
BF834526 head_neck .h 865 to 1137 1 to 269       269/269
(100 %)
7 diff
(97.4 %id)
BF921659 nervous_tumor .h 881 to 1176 9 to 304       296/304
(97 %)
6 diff
(98.1 %id)
BG946099 bladder_tumor .h 959 to 1510 589 to 30       560/607
(92 %)
0 diff
(100 %id)
BI036699 nervous_tumor .h 967 to 1279 1 to 310       310/314
(98 %)
16 diff
(95.0 %id)
BQ721924 sympathetic trunk .h 990 to 1844 900 to 43   tiling clone, AAA Submitted on the opposite strand 858/858
(100 %)
6 diff
(99.4 %id)
BQ344478 nervous_tumor .h 1028 to 1471 455 to 12       444/455
(97 %)
0 diff
(100 %id)
BX454841 brain, fetal brain .h 1056 to 1841 792 to 1   fully sequenced,   792/792
(100 %)
21 diff
(97.4 %id)
BQ776126 Bone, Human Chondrosarcoma Cell Line .h 1134 to 1844 728 to 19   AAA   710/710
(100 %)
1 diff
(99.9 %id)
AI355746 lung .h 1297 to 1737 441 to 1       441/441
(100 %)
0 diff
(100 %id)
CB128439 Liver .i 1 to 649 1 to 649 E51D tiling clone,   649/649
(100 %)
1 diff
(99.9 %id)
BX109921   .j-u 1 to 447 1 to 447 exact tiling clone,   447/450
(99 %)
3 diff
(99.4 %id)
AI014901   .j-u 6 to 487 480 to 1 E2K A3R S4L P5R L6C ... tiling clone,   480/480
(100 %)
9 diff
(98.2 %id)
AI219737 pooled .j-u 14 to 487 474 to 1 E2K K17E tiling clone,   474/474
(100 %)
4 diff
(99.2 %id)
BE675580 B-cell, chronic lymphotic leukemia .j-u 36 to 487 452 to 1 exact     452/452
(100 %)
1 diff
(99.8 %id)
AA765382 germinal center B cell .j-u 76 to 417 342 to 1       342/342
(100 %)
4 diff
(98.9 %id)
AW138408   .j-u 181 to 486 306 to 1       306/306
(100 %)
0 diff
(100 %id)
AI913215 Kidney .j-u 187 to 487 302 to 1       302/302
(100 %)
4 diff
(98.7 %id)
BG944570 blood .k 1 to 214 1 to 214 exact tiling clone,   214/214
(100 %)
1 diff
(99.6 %id)
BP387012 pancreatic islet Gene HMGB2, variant not shown         Submitted on the opposite strand    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j-u, .k Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI